{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T12:57:33Z","timestamp":1781355453676,"version":"3.54.1"},"reference-count":128,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.retram.2016.03.003","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T16:50:50Z","timestamp":1464713450000},"page":"71-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Haematopoietic stem cell transplantation in autoimmune diseases: From basic science to clinical practice"],"prefix":"10.1016","volume":"64","author":[{"given":"P.J.","family":"Kelsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-C.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Badoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Sharrack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Farge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Snowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.retram.2016.03.003_bib0005","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/bmt.2011.185","article-title":"Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation","volume":"47","author":"Snowden","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.retram.2016.03.003_bib0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/bmt.2014.251","article-title":"SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking","volume":"50","author":"Alexander","year":"2015","journal-title":"Bone Marrow Transplantation"},{"issue":"12","key":"10.1016\/j.retram.2016.03.003_bib0015","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/sj.bmt.1700815","article-title":"Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin's lymphoma","volume":"19","author":"Snowden","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.retram.2016.03.003_bib0020","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2141.2004.05298.x","article-title":"Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective","volume":"128","author":"Hough","year":"2005","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.retram.2016.03.003_bib0025","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1002\/art.22256","article-title":"Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens","volume":"54","author":"Burt","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.retram.2016.03.003_bib0030","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.4049\/jimmunol.118.5.1858","article-title":"Evidence for a B lymphocyte defect underlying the anti-X anti-erythrocyte autoantibody response of NZB mice","volume":"5","author":"de Heer","year":"1977","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.retram.2016.03.003_bib0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00007890-197902000-00012","article-title":"Transplantation of autoimmune potential. IV. Reversal of the NZB autoimmune syndrome by bone marrow transplantation","volume":"27","author":"Morton","year":"1979","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.retram.2016.03.003_bib0040","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.4049\/jimmunol.127.3.1232","article-title":"Reciprocal transfer of abnormalities in clonable B lymphocytes and myeloid progenitors between NZB and DBA\/2 mice","volume":"127","author":"Jyonouchi","year":"1981","journal-title":"J Immunol"},{"key":"10.1016\/j.retram.2016.03.003_bib0045","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1749-6632.1983.tb22217.x","article-title":"Rectification of immunological abnormalities and lupus nephritis by the transfer of bone marrow cells","volume":"420","author":"Shiraki","year":"1983","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.retram.2016.03.003_bib0050","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1073\/pnas.82.8.2483","article-title":"Rationale for bone marrow transplantation in the treatment of autoimmune diseases","volume":"82","author":"Ikehara","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.retram.2016.03.003_bib0055","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1073\/pnas.86.9.3306","article-title":"Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation","volume":"86","author":"Ikehara","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.retram.2016.03.003_bib0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2249.1995.tb03611.x","article-title":"Immunomodulation of autoimmunity in MRL\/lpr mice with syngeneic bone marrow transplantation (SBMT)","volume":"100","author":"Karussis","year":"1995","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.retram.2016.03.003_bib0065","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1182\/blood.V82.10.3091.3091","article-title":"Prevention and induction of occlusive coronary vascular disease in autoimmune (W\/B)F1 mice by haploidentical bone marrow transplantation: possible role for anticardiolipin autoantibodies","volume":"82","author":"Mizutani","year":"1993","journal-title":"Blood"},{"issue":"3\u20134","key":"10.1016\/j.retram.2016.03.003_bib0070","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0171-2985(11)80099-9","article-title":"Effect of\u00a0bone marrow\u00a0transplantation on\u00a0antiphospholipid\u00a0antibody syndrome in murine lupus mice","volume":"192","author":"Adachi","year":"1995","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.retram.2016.03.003_bib0075","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/cimm.1995.1061","article-title":"Beneficial effects of bone marrow transplantation on the serological manifestations and kidney pathology of experimental systemic lupus erythematosus","volume":"162","author":"Levite","year":"1995","journal-title":"Cell Immunol"},{"issue":"2","key":"10.1016\/j.retram.2016.03.003_bib0080","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-3083.1995.tb03649.x","article-title":"Induction\u00a0of tolerance to experimental anti-phospholipid syndrome (APS) by syngeneic bone marrow cell transplantation","volume":"42","author":"Blank","year":"1995","journal-title":"Scand J Immunol"},{"issue":"24","key":"10.1016\/j.retram.2016.03.003_bib0085","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1073\/pnas.86.24.10090","article-title":"Regression of adjuvant-induced arthritis in rats following bone marrow transplantation","volume":"86","author":"Van Bekkum","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.retram.2016.03.003_bib0090","first-page":"225","article-title":"Effective treatment of mice with type II collagen induced arthritis with lethal irradiation and bone marrow transplantation","volume":"20","author":"Kamiya","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.retram.2016.03.003_bib0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/art.1780360220","article-title":"Prevention of autoimmune inflammatory polyarthritis in male new zealand black\/kn mice by transplantation of bone marrow cells plus bone (stromal cells)","volume":"36","author":"Nakagawa","year":"1993","journal-title":"Arthritis Rheum"},{"issue":"22","key":"10.1016\/j.retram.2016.03.003_bib0100","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1073\/pnas.82.22.7743","article-title":"Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation","volume":"82","author":"Ikehara","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10.1016\/j.retram.2016.03.003_bib0105","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1073\/pnas.84.18.6555","article-title":"Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue","volume":"84","author":"Yasumizu","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.retram.2016.03.003_bib0110","first-page":"2896","article-title":"Bone marrow transplantation prevents autoimmune diabetes in nonobese diabetic mice","volume":"25","author":"Georgiou","year":"1993","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.retram.2016.03.003_bib0115","first-page":"233","article-title":"Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT","volume":"11","author":"van Gelder","year":"1993","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.retram.2016.03.003_bib0120","first-page":"343","article-title":"Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain","volume":"16","author":"van Gelder","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.retram.2016.03.003_bib0125","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.4049\/jimmunol.148.6.1693","article-title":"Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation","volume":"148","author":"Karussis","year":"1992","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.retram.2016.03.003_bib0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0165-5728(92)90254-I","article-title":"Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation","volume":"39","author":"Karussis","year":"1992","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.retram.2016.03.003_bib0135","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1172\/JCI116648","article-title":"Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation","volume":"92","author":"Karussis","year":"1993","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.retram.2016.03.003_bib0140","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/jnr.490410412","article-title":"Syngeneic bone marrow transplantation eliminates V beta 8.2T lymphocytes from the spinal cord of\u00a0Lewis\u00a0rats with experimental allergic encephalomyelitis","volume":"41","author":"Burt","year":"1995","journal-title":"J Neurosci Res"},{"issue":"1","key":"10.1016\/j.retram.2016.03.003_bib0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/mus.880050115","article-title":"Treatment of ongoing experimental myasthenia gravis with short term high dose cyclophosphamide","volume":"5","author":"Pestronk","year":"1982","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.retram.2016.03.003_bib0150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.410140210","article-title":"Combined short-term immunotherapy for experimental autoimmune myasthenia gravis","volume":"14","author":"Pestronk","year":"1983","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.retram.2016.03.003_bib0155","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1084\/jem.179.3.1053","article-title":"Focal segmental glomerular sclerosis, a type of intractable chronic glomerulonephritis, is a stem cell disorder","volume":"179","author":"Nishimura","year":"1994","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.retram.2016.03.003_bib0160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1023\/A:1006682225181","article-title":"Stem cell\u00a0transplantation\u00a0in experimental models of autoimmune disease","volume":"20","author":"van Bekkum","year":"2000","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.retram.2016.03.003_bib0165","first-page":"567","article-title":"Adoptive transfer of the diseases of New Zealand black mice to normal mice strains","volume":"5","author":"Denman","year":"1969","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.retram.2016.03.003_bib0170","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.71.6.2162","article-title":"Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand black mice","volume":"71","author":"Morton","year":"1974","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.retram.2016.03.003_bib0175","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/00007890-197406000-00012","article-title":"Letter: early autoantibody formation in lethally irradiated or drug-treated H-2-compatible recipients of pre-autoimmune NZB bone marrow or fetal liver cells","volume":"17","author":"Morton","year":"1974","journal-title":"Transplantation"},{"issue":"21","key":"10.1016\/j.retram.2016.03.003_bib0180","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.1073\/pnas.87.21.8341","article-title":"Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells","volume":"87","author":"Ikehara","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.retram.2016.03.003_bib0185","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0090-1229(78)90177-0","article-title":"Expression of autoimmunity by NZB\/NZW marrow","volume":"10","author":"Akizuki","year":"1978","journal-title":"Clin Immunol Immunopathol"},{"issue":"5","key":"10.1016\/j.retram.2016.03.003_bib0190","first-page":"333","article-title":"Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation","volume":"8","author":"Knaan-Shanzer","year":"1991","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.retram.2016.03.003_bib0195","first-page":"1029","article-title":"Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation","volume":"18","author":"van Gelder","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.retram.2016.03.003_bib0200","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/1352458506071301","article-title":"Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database","volume":"12","author":"Saccardi","year":"2006","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.retram.2016.03.003_bib0205","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1182\/blood-2003-03-0877","article-title":"Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores","volume":"102","author":"Burt","year":"2003","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.retram.2016.03.003_bib0210","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood-2002-12-3908","article-title":"High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis","volume":"102","author":"Nash","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2016.03.003_bib0215","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1023\/A:1006686426090","article-title":"Autologous stem cell transplantation in progressive multiple sclerosis\u00a0\u2013\u00a0an interim analysis of efficacy","volume":"20","author":"Fassas","year":"2000","journal-title":"J Clin Immunol"},{"issue":"8","key":"10.1016\/j.retram.2016.03.003_bib0220","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.bmt.1700944","article-title":"Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study","volume":"20","author":"Fassas","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.retram.2016.03.003_bib0225","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1212\/WNL.56.8.1084","article-title":"MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS","volume":"56","author":"Saiz","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.retram.2016.03.003_bib0230","first-page":"306","article-title":"CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients","volume":"88","author":"Carreras","year":"2003","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.retram.2016.03.003_bib0235","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0041-1345(01)01933-9","article-title":"Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis","volume":"33","author":"Koz\u00e1k","year":"2001","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.retram.2016.03.003_bib0240","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.bmt.1702180","article-title":"High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis","volume":"25","author":"Koz\u00e1k","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.retram.2016.03.003_bib0245","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/jnnp.2005.063883","article-title":"Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis","volume":"77","author":"Samijn","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.retram.2016.03.003_bib0250","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/art.10495","article-title":"A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis","volume":"46","author":"Moore","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.retram.2016.03.003_bib0255","first-page":"1653","article-title":"High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists","volume":"29","author":"Verburg","year":"2002","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.retram.2016.03.003_bib0260","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood-2007-02-072389","article-title":"High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study","volume":"110","author":"Nash","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.retram.2016.03.003_bib0265","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.bmt.1705782","article-title":"Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis","volume":"40","author":"Oyama","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.retram.2016.03.003_bib0270","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/1352458512438454","article-title":"A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper","volume":"18","author":"Saccardi","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.retram.2016.03.003_bib0275","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2377-14-58","article-title":"Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis","volume":"14","author":"Meyer-Moock","year":"2014","journal-title":"BMC Neurol"},{"key":"10.1016\/j.retram.2016.03.003_bib0280","series-title":"Long term outcomes after autologous hematopoietic stem cell transplantation for treatment of MS","first-page":"116682","author":"Muraro","year":"2015"},{"issue":"10","key":"10.1016\/j.retram.2016.03.003_bib0285","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1136\/jnnp-2013-307207","article-title":"Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience","volume":"85","author":"Burman","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.retram.2016.03.003_bib0290","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jamaneurol.2014.3780","article-title":"High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report","volume":"72","author":"Nash","year":"2015","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.retram.2016.03.003_bib0295","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2014.17986","article-title":"Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis","volume":"313","author":"Burt","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.retram.2016.03.003_bib0300","series-title":"Stem cell therapy for patients with multiple sclerosis failing alternate approved therapy\u00a0\u2013\u00a0A randomized study. In ClinicalTrial. gov [Internet]","author":"Burt","year":"2015"},{"issue":"10","key":"10.1016\/j.retram.2016.03.003_bib0305","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1212\/WNL.0000000000001329","article-title":"Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial","volume":"84","author":"Mancardi","year":"2015","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.retram.2016.03.003_bib0310","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrrheum.2011.152","article-title":"Connective tissue diseases: predicting death in SSc: planning and cooperation are needed","volume":"7","author":"Domsic","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"10.1016\/j.retram.2016.03.003_bib0315","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/ard.2010.144360","article-title":"Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres","volume":"70","author":"Fransen","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.retram.2016.03.003_bib0320","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/ard.2003.011205","article-title":"Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT\/EULAR Registry","volume":"63","author":"Farge","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.retram.2016.03.003_bib0325","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/ard.2007.071464","article-title":"Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis","volume":"67","author":"Vonk","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"9790","key":"10.1016\/j.retram.2016.03.003_bib0330","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.retram.2016.03.003_bib0335","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"Van Laar","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.retram.2016.03.003_bib0340","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3899\/jrheum.121087","article-title":"Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial","volume":"40","author":"Hung","year":"2013","journal-title":"J Rheumatol"},{"issue":"9872","key":"10.1016\/j.retram.2016.03.003_bib0345","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(12)62114-X","article-title":"Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis","volume":"381","author":"Burt","year":"2013","journal-title":"Lancet"},{"issue":"9872","key":"10.1016\/j.retram.2016.03.003_bib0350","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(12)62176-X","article-title":"Improving safety in autologous HSCT for systemic sclerosis","volume":"381","author":"Snowden","year":"2013","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.retram.2016.03.003_bib0355","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1182\/blood.V100.5.1602.h81702001602_1602_1610","article-title":"High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes","volume":"100","author":"McSweeney","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.retram.2016.03.003_bib0360","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood-2007-02-072389","article-title":"High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study","volume":"110","author":"Nash","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.retram.2016.03.003_bib0365","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.ijrobp.2010.05.036","article-title":"Renal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation on the SCOT (scleroderma: cyclophosphamide or transplantation) trial","volume":"79","author":"Cracinescu","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.retram.2016.03.003_bib0370","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/bmt.2015.299","article-title":"Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?","volume":"51","author":"Oliveira","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.retram.2016.03.003_bib0375","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.295.5.527","article-title":"Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus","volume":"295","author":"Burt","year":"2006","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.retram.2016.03.003_bib0380","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1191\/0961203304lu525oa","article-title":"Autologous stem cell transplantation for systemic lupus erythematosus","volume":"13","author":"Jayne","year":"2004","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.retram.2016.03.003_bib0385","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0961203312470729","article-title":"Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry","volume":"22","author":"Alchi","year":"2013","journal-title":"Lupus"},{"issue":"12","key":"10.1016\/j.retram.2016.03.003_bib0390","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1136\/ard.2010.148049","article-title":"Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus","volume":"70","author":"Illei","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.retram.2016.03.003_bib0395","first-page":"482","article-title":"Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR","volume":"31","author":"Snowden","year":"2004","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.retram.2016.03.003_bib0400","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","article-title":"Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type","volume":"48","author":"Quartier","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.retram.2016.03.003_bib0405","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/art.20944","article-title":"Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis","volume":"52","author":"Yokota","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.retram.2016.03.003_bib0410","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.22656","article-title":"Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial","volume":"56","author":"Brinkman","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.retram.2016.03.003_bib0415","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/ard.2006.056630","volume":"66","author":"Daikeler","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.retram.2016.03.003_bib0420","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/ard.2008.094755","article-title":"Antisignal recognition particle-positive polymyositis successfully treated with myeloablative autologous stem cell transplantation","volume":"68","author":"Henes","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.retram.2016.03.003_bib0425","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/03009740903096622","article-title":"Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis","volume":"39","author":"Holzer","year":"2010","journal-title":"Scand J Rheumatol"},{"issue":"9300","key":"10.1016\/j.retram.2016.03.003_bib0430","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0140-6736(02)07284-7","article-title":"Crohn's disease","volume":"359","author":"Shanahan","year":"2002","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.retram.2016.03.003_bib0435","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1182\/blood-2010-06-292391","article-title":"Autologous nonmyeloblative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long term follow-up","volume":"116","author":"Burt","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.retram.2016.03.003_bib0440","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/gut.2007.128694","article-title":"Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease","volume":"57","author":"Cassinotti","year":"2008","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.retram.2016.03.003_bib0445","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/apt.12032","article-title":"Remission of refractory Crohn's disease by high-dose cyclophosphamide and autologous peripheral blood\u00a0stem cell\u00a0transplantation","volume":"36","author":"Hasselblatt","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.retram.2016.03.003_bib0450","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.crohns.2011.05.004","article-title":"Long-term follow-up of autologous hematopoietic\u00a0stem cell\u00a0transplantation for severe refractory Crohn's disease","volume":"5","author":"Hommes","year":"2011","journal-title":"J Crohns Colitis"},{"issue":"23","key":"10.1016\/j.retram.2016.03.003_bib0455","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.2015.16700","article-title":"Autologous hematopoetic stem cell transplantation for refractory Crohn disease: a randomized clinical trial","volume":"314","author":"Hawkey","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.retram.2016.03.003_bib0460","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/jnnp-2013-306014","article-title":"Autologous haematopoetic stem cell transplantatiom: a viable treatment option for CIDP","volume":"85","author":"Press","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"18","key":"10.1016\/j.retram.2016.03.003_bib0465","doi-asserted-by":"crossref","first-page":"18023","DOI":"10.1212\/01.wnl.0000277266.53449.8b","article-title":"Nonmyeloablativeautologous hematopoietic stem celltransplantation for refractory\u00a0CIDP","volume":"69","author":"Oyama","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.retram.2016.03.003_bib0470","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1529-8027.2009.00221.x","article-title":"Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropath","volume":"14","author":"Mahdi-Rogers","year":"2009","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.retram.2016.03.003_bib0475","series-title":"Haematopoetic stem cell transplantation in chronic inflammatory demyelinating polyneuropathy. In ClinicalTrial. gov [Internet]","author":"Burt","year":"2015"},{"issue":"2","key":"10.1016\/j.retram.2016.03.003_bib0480","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1352458514541978","article-title":"Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT Autoimmune Diseases Working Party","volume":"21","author":"Greco","year":"2015","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.retram.2016.03.003_bib0485","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archneurol.2011.38","article-title":"Failure of autologous hematopoietic stem cell transplantation to prevent relapse of neuromyelitis optica","volume":"68","author":"Matiello","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.retram.2016.03.003_bib0490","article-title":"Efficacy of rituximab in refractory neuromyelitis optica","author":"Collongues","year":"2015","journal-title":"Mult Scler"},{"issue":"10","key":"10.1016\/j.retram.2016.03.003_bib0495","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/jamaneurol.2014.1297","article-title":"Autologous stem cell transplantation for stiff person syndrome: two cases from the Ottawa blood and marrow transplant program","volume":"71","author":"Sanders","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.retram.2016.03.003_bib0500","series-title":"Haematopoetic stem cell transplantation for Stiff Person Syndrome. In ClinicalTrial. gov [Internet]","author":"Burt","year":"2015"},{"issue":"21","key":"10.1016\/j.retram.2016.03.003_bib0505","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1182\/blood.V124.21.3996.3996","article-title":"Autologous stem cell transplant for Myasthenia gravis: a single-centre experience","volume":"124","author":"Bryant","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.retram.2016.03.003_bib0510","series-title":"Haematopoetic stem therapy for patients with refractory Myasthenia gravis. In ClinicalTrial. gov [Internet]","author":"Burt","year":"2015"},{"issue":"6","key":"10.1016\/j.retram.2016.03.003_bib0515","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2141.2004.04978.x","article-title":"Haematopoetic stem cell transplantation for refractory autoimmune cytopenia","volume":"125","author":"Passweg","year":"2004","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.retram.2016.03.003_bib0520","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbmt.2012.12.008","article-title":"Long-term outcomes of hematopoietic stem cell transplantation for severe treatment-resistant autoimmune cytopenia in children","volume":"19","author":"Rabusin","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.retram.2016.03.003_bib0525","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2337\/dc11-2161","article-title":"Diabetic ketoacidosis at diagnosis influences complete remission after treatment with hematopoietic stem cell transplantation in adolescents with type 1 diabetes","volume":"35","author":"Gu","year":"2012","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.retram.2016.03.003_bib0530","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/bmt.2010.147","article-title":"Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes\u00a0type I","volume":"46","author":"Snarski","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"15","key":"10.1016\/j.retram.2016.03.003_bib0535","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.2009.470","article-title":"C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus","volume":"301","author":"Couri","year":"2009","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.retram.2016.03.003_bib0540","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.2337\/db14-0295","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis","volume":"63","author":"D\u2019Addio","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.retram.2016.03.003_bib0545","first-page":"2618","article-title":"Autologous hematopoietic stem cell transplantation and conventional insulin therapy in the treatment of children with newly diagnosed type 1 diabetes: long-term follow-up","volume":"127","author":"Yi","year":"2014","journal-title":"Chin Med J"},{"issue":"1","key":"10.1016\/j.retram.2016.03.003_bib0550","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/bmt.2008.424","article-title":"Allogeneic hematopoietic SCT for patients with autoimmune diseases","volume":"44","author":"Daikeler","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.retram.2016.03.003_bib0555","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bbmt.2006.04.007","article-title":"Pure white cell aplasia (PWCA) relapsing after allogeneic BMT and successfully treated with nine DLIs","volume":"12","author":"Marmont","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.retram.2016.03.003_bib0560","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.bmt.1703833","article-title":"Refractory Evans\u2019 syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect","volume":"31","author":"Marmont","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.retram.2016.03.003_bib0565","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/ana.24079","article-title":"Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica","volume":"75","author":"Greco","year":"2014","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.retram.2016.03.003_bib0570","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1002\/art.21380","article-title":"Sustained remission, possibly cure, of seronegative arthritis after high-dose chemotherapy and syngeneic hematopoietic stem cell transplantation","volume":"52","author":"McColl","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.retram.2016.03.003_bib0575","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1136\/ard.2004.034793","article-title":"High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host autoantibodies and synovial abnormalities","volume":"64","author":"Van Oosterhout","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.retram.2016.03.003_bib0580","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/08916930802198550","article-title":"Stem cell transplantation in rheumatoid arthritis","volume":"41","author":"Snowden","year":"2008","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.retram.2016.03.003_bib0585","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1172\/JCI71691","article-title":"T cell repertoire following autologous stem cell transplantation for multiple sclerosis","volume":"124","author":"Muraro","year":"2014","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.retram.2016.03.003_bib0590","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20041679","article-title":"Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients","volume":"201","author":"Muraro","year":"2005","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.retram.2016.03.003_bib0595","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1182\/blood-2015-11-678607","article-title":"Re-booting autoimmunity with autologous HSCT (review)","volume":"127","author":"Snowden","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.retram.2016.03.003_bib0600","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1182\/blood-2005-06-2269","article-title":"Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin","volume":"107","author":"Zand","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.retram.2016.03.003_bib0605","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1182\/blood-2007-12-128488","article-title":"Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+ CD25+ Foxp3+ regulatory T cells","volume":"111","author":"Roord","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.retram.2016.03.003_bib0610","article-title":"Autologous stem cell transplantation benefits autoimmune patients through functional renewal and TCR diversification of the regulatory T cell compartment","author":"Delemarre","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.retram.2016.03.003_bib0615","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/art.21036","article-title":"Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis","volume":"52","author":"Farge","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.retram.2016.03.003_bib0620","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","article-title":"Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system","volume":"113","author":"Alexander","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.retram.2016.03.003_bib0625","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.retram.2016.03.003_bib0630","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/ar1452","article-title":"Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia","volume":"7","author":"Ponchel","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.retram.2016.03.003_bib0635","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1182\/blood-2011-02-336156","article-title":"Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party","volume":"118","author":"Daikeler","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.retram.2016.03.003_bib0640","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/blood-2006-07-035766","article-title":"Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used","volume":"109","author":"Loh","year":"2007","journal-title":"Blood"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318616300010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318616300010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T17:56:06Z","timestamp":1692381366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318616300010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":128,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S2452318616300010"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2016.03.003","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haematopoietic stem cell transplantation in autoimmune diseases: From basic science to clinical practice","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2016.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}